Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Inclusion Criteria: * Be a female diagnosed with endometrial cancer and scheduled for UAE. * Be over the age of 18 years. * If the subject is of child-bearing potential, must have a negative pregnancy test. * Be conscious and able to comply with study procedures. * Have read and signed the IRB approved consent form for participating in the study. Exclusion Criteria: * Females who are pregnant or nursing. * Patients who have received an investigational drug in the 30 days before study drug administration, or will receive one within 72 hours afterwards. * Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example: * Patients on life support or in a critical care unit. * Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia. * Patients with recent cerebral hemorrhage. * Patients who have undergone surgery within 24 hours prior to the study sonographic examination. * Patients with congenital heart defects. * Patient with a known allergy to Definity.